APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease

APOE4 依赖性调节脑脊液补体通路激活在阿尔茨海默病的发展过程中

基本信息

  • 批准号:
    10871775
  • 负责人:
  • 金额:
    $ 40.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

Dementia is a common disorder that increases in frequency in the elderly. Dementia is a progressive loss of thinking and memory skills that eventually results in an inability to care for oneself and to live independently. The most common cause of dementia in older Americans is Alzheimer’s Disease, which develops as a result of multiple lifestyle/environmental factors and inherited or familial causes. Many familial traits (such as the risk of developing Alzheimer’s disease) are inherited genetically, through gene variants (sequences of a chemical code called DNA). The most common genetic variant that increases the risk of Alzheimer’s disease is called APOE4. Although we have known for over 25 years that inheriting an APOE4 genetic variant (also called an allele) increases Alzheimer’s disease risk, it is unclear how and why APOE4 increases this risk. Recent data has raised the possibility that APOE4 may act by increasing the activation of the complement pathway, a set of proteins that are used by immune cells to kill and eat bacteria, and that also play a role in “killing” and “eating” connections between nerve cells in the brain, known as synapses. In this project, we will examine whether people that carry the APOE4 allele (either 1 or 2 copies of this allele) have increased evidence of complement pathway activation in the fluid that bathes their brain and spinal cord, known as the cerebrospinal fluid (CSF) across the full adult lifespan. We have begun to assemble a set of CSF samples from our own studies as well as biobanks in the US and Europe. To date we have collected or received approval to use CSF samples from 400 individuals. This administrative supplement will allow us to recruit additional subjects between the ages of 18-39 to complete the set of CSF samples needed for this analysis. These samples will be analyzed using an advanced method that can measure the levels of a large percentage of all proteins present in human CSF, and which can precisely measure the levels of proteins in the complement pathway. Overall, this work will help us understand how and why APOE4 changes the function of the brain, and how and why it contributes to AD risk. This work is an early step towards identifying proteins or pathways that could be targeted by drugs to prevent Alzheimer’s disease in people that carry an APOE4 allele before the onset of any clinical symptoms.
痴呆症是一种常见的疾病,在老年人中发生频率增加。痴呆是一 逐渐丧失思维和记忆能力,最终导致无法照顾 自己,独立生活。美国老年痴呆症最常见的原因是 阿尔茨海默病,由于多种生活方式/环境因素而发展, 遗传或家族原因。许多家族特征(如患老年痴呆症的风险 疾病)是遗传的,通过基因变异(化学密码序列,称为 DNA)。最常见的增加阿尔茨海默病风险的遗传变异被称为 APOE 4.虽然我们已经知道超过25年,遗传APOE 4遗传变异(也 称为等位基因)增加阿尔茨海默病的风险,目前还不清楚APOE 4如何以及为什么增加 这个风险。最近的数据表明,APOE 4可能通过增加细胞的活化来发挥作用。 补体途径是一组被免疫细胞用来杀死和吃掉细菌的蛋白质, 并且在“杀死”和“吃掉”大脑中神经细胞之间的连接中也起着作用, 称为突触。在这个项目中,我们将检查携带APOE 4等位基因的人是否 (该等位基因的1个或2个拷贝)的补体途径激活的证据增加, 脑脊髓液(CSF)是一种浸泡大脑和脊髓的液体, 成年人的全部寿命。我们已经开始收集一组我们自己研究的脑脊液样本 以及美国和欧洲的生物银行。到目前为止,我们已经收集或获得批准, 使用来自400个人的CSF样本。这份行政补助将使我们能够招募 年龄在18-39岁之间的额外受试者,以完成所需的CSF样本集, 这个分析。这些样本将使用先进的方法进行分析, 人CSF中存在的所有蛋白质的大百分比的水平,并且其可以精确地 测量补体途径中的蛋白质水平。总的来说,这项工作将有助于我们 了解APOE 4如何以及为什么改变大脑的功能,以及它如何以及为什么改变大脑的功能。 增加AD风险。这项工作是识别蛋白质或途径的早期步骤, 可以被药物靶向预防携带APOE 4等位基因的人患阿尔茨海默病 在任何临床症状出现之前

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Miles Berger其他文献

Miles Berger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Miles Berger', 18)}}的其他基金

APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
APOE4 依赖性调节脑脊液补体通路激活在阿尔茨海默病的发展过程中
  • 批准号:
    10650372
  • 财政年份:
    2022
  • 资助金额:
    $ 40.22万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10870632
  • 财政年份:
    2022
  • 资助金额:
    $ 40.22万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10671023
  • 财政年份:
    2022
  • 资助金额:
    $ 40.22万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10521860
  • 财政年份:
    2022
  • 资助金额:
    $ 40.22万
  • 项目类别:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
术后认知功能障碍中的神经炎症:脑脊液和功能磁共振成像研究
  • 批准号:
    9390592
  • 财政年份:
    2017
  • 资助金额:
    $ 40.22万
  • 项目类别:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
术后认知功能障碍中的神经炎症:脑脊液和功能磁共振成像研究
  • 批准号:
    10598925
  • 财政年份:
    2017
  • 资助金额:
    $ 40.22万
  • 项目类别:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
术后认知功能障碍中的神经炎症:脑脊液和功能磁共振成像研究
  • 批准号:
    9898206
  • 财政年份:
    2017
  • 资助金额:
    $ 40.22万
  • 项目类别:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
术后认知功能障碍中的神经炎症:脑脊液和功能磁共振成像研究
  • 批准号:
    10160751
  • 财政年份:
    2017
  • 资助金额:
    $ 40.22万
  • 项目类别:
The Significance of Perioperative Changes in CSF tau levels in the Elderly
老年人围手术期脑脊液 tau 水平变化的意义
  • 批准号:
    9123506
  • 财政年份:
    2015
  • 资助金额:
    $ 40.22万
  • 项目类别:
Role of 5-HT1A-AR overexpression in affective disorders
5-HT1A-AR 过表达在情感障碍中的作用
  • 批准号:
    7281976
  • 财政年份:
    2005
  • 资助金额:
    $ 40.22万
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
Sedentary behavior, physical activity, and 24-hour behavior in pregnancy and offspring health: the Pregnancy 24/7 Offspring Study Administrative Supplement
久坐行为、体力活动和 24 小时行为对怀孕和后代健康的影响:怀孕 24/7 后代研究行政补充
  • 批准号:
    10893074
  • 财政年份:
    2023
  • 资助金额:
    $ 40.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了